Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 3NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Other solid neoplasm 1Gynecologic 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Gemcitabine 3Carboplatin 3cabozantinib 2Magnetic Resonance Spectroscopy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Filgrastim 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1siltuximab 1pembrolizumab 1peginterferon alfa-2b 1pegfilgrastim 1pazopanib 1lenvatinib 1fludarabine 1aldesleukin 1Vincristine 1Thrombopoietin 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Renal Cell × Granulocyte Colony-Stimulating Factor × Clear all
NCT00068393 2023-07-07

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Eastern Cooperative Oncology Group

Phase 2 Completed
39 enrolled 7 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003597 2014-07-24

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
16 enrolled
CNSClassical hematologyDermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡